Orange Book product · Generic (ANDA)
RESERPINE AND HYDROCHLOROTHIAZIDE-50
HYDROCHLOROTHIAZIDE; RESERPINE
At a glance
May 10, 1984
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 10, 1984
42 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
HYDROCHLOROTHIAZIDE; RESERPINE
Strength
50MG;0.125MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 088189
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of HYDROCHLOROTHIAZIDE; RESERPINE
- —HYDROPRES 25Brand (NDA)
NDA 011958 · MERCK
- —SERPASIL-ESIDRIX #1Brand (NDA)
NDA 011878 · NOVARTIS
- 1984RESERPINE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 088200 · SANDOZ
- 1982HYDRO-RESERPGeneric (ANDA)
ANDA 084714 · ABC HOLDING
- —H.R.-50Generic (ANDA)
ANDA 085338 · WHITEWORTH TOWN PLSN
- —"HYDRO-SERP ""25"""Generic (ANDA)
ANDA 084827 · SANDOZ
- —"HYDRO-SERP ""50"""Generic (ANDA)
ANDA 085213 · SANDOZ
- —HYDROCHLOROTHIAZIDE W/ RESERPINEGeneric (ANDA)
ANDA 083572 · IVAX SUB TEVA PHARMS
- —HYDROCHLOROTHIAZIDE W/ RESERPINEGeneric (ANDA)
ANDA 083571 · IVAX SUB TEVA PHARMS
- —HYDROCHLOROTHIAZIDE W/ RESERPINEGeneric (ANDA)
ANDA 083568 · IVAX SUB TEVA PHARMS
- —HYDROCHLOROTHIAZIDE W/ RESERPINEGeneric (ANDA)
ANDA 083573 · IVAX SUB TEVA PHARMS
- —HYDROCHLOROTHIAZIDE W/ RESERPINEGeneric (ANDA)
ANDA 085421 · PHARMERAL
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
